Katoh, N., Ohya, Y., Murota, H., Ikeda, M., Hu, X., Ikeda, K., . . . Saeki, H. (2021). A phase 3 randomized, multicenter, double-blind study to evaluate the safety of upadacitinib in combination with topical corticosteroids in adolescent and adult patients with moderate-to-severe atopic dermatitis in Japan (Rising Up): An interim 24-week analysis.
Chicago Style (17th ed.) CitationKatoh, Norito, et al. A Phase 3 Randomized, Multicenter, Double-blind Study to Evaluate the Safety of Upadacitinib in Combination with Topical Corticosteroids in Adolescent and Adult Patients with Moderate-to-severe Atopic Dermatitis in Japan (Rising Up): An Interim 24-week Analysis. 2021.
MLA引文Katoh, Norito, et al. A Phase 3 Randomized, Multicenter, Double-blind Study to Evaluate the Safety of Upadacitinib in Combination with Topical Corticosteroids in Adolescent and Adult Patients with Moderate-to-severe Atopic Dermatitis in Japan (Rising Up): An Interim 24-week Analysis. 2021.